Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections
出版年份 2013 全文链接
标题
Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections
作者
关键词
-
出版物
Expert Opinion on Drug Metabolism & Toxicology
Volume 9, Issue 7, Pages 911-926
出版商
Informa Healthcare
发表日期
2013-05-06
DOI
10.1517/17425255.2013.794785
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pharmacodynamics of Itraconazole against Aspergillus fumigatus in anIn VitroModel of the Human Alveolus: Perspectives on the Treatment of Triazole-Resistant Infection and Utility of Airway Administration
- (2012) Zaid Al-Nakeeb et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Azole Resistance by Loss of Function of the Sterol Δ5,6-Desaturase Gene (ERG3) in Candida albicans Does Not Necessarily Decrease Virulence
- (2012) L. A. Vale-Silva et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The T788G Mutation in thecyp51CGene Confers Voriconazole Resistance in Aspergillus flavus Causing Aspergillosis
- (2012) Wei Liu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- EUCAST Technical Note on Aspergillus and amphotericin B, itraconazole, and posaconazole
- (2012) M.C. Arendrup et al. CLINICAL MICROBIOLOGY AND INFECTION
- Identification of novel genes conferring altered azole susceptibility in Aspergillus fumigatus
- (2012) Paul Bowyer et al. FEMS MICROBIOLOGY LETTERS
- High-level expression of cyp51B in azole-resistant clinical Aspergillus fumigatus isolates
- (2012) A. Buied et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In Vivo Emergence of Aspergillus terreus with Reduced Azole Susceptibility and a Cyp51a M217I Alteration
- (2012) Maiken C. Arendrup et al. JOURNAL OF INFECTIOUS DISEASES
- Clonal Expansion and Emergence of Environmental Multiple-Triazole-Resistant Aspergillus fumigatus Strains Carrying the TR34/L98H Mutations in the cyp51A Gene in India
- (2012) Anuradha Chowdhary et al. PLoS One
- An Improved Model of the Aspergillus fumigatus CYP51A Protein
- (2011) M. G. Fraczek et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rapid Induction of Multiple Resistance Mechanisms in Aspergillus fumigatus during Azole Therapy: a Case Study and Review of the Literature
- (2011) Simone M. T. Camps et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antifungal Susceptibilities of Aspergillus fumigatus Clinical Isolates Obtained in Nagasaki, Japan
- (2011) Masato Tashiro et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in thecyp51AGene
- (2011) Shawn R. Lockhart et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High-frequency Triazole Resistance Found In Nonculturable Aspergillus fumigatus from Lungs of Patients with Chronic Fungal Disease
- (2011) David W. Denning et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
- (2011) Alison G. Freifeld et al. CLINICAL INFECTIOUS DISEASES
- Chitosan-coated liposomes for intracellular oligonucleotides delivery: Characteristics and cell uptake behavior
- (2011) Wen-Xi Wang et al. DRUG DELIVERY
- Peripheral neuropathy in patients on long-term triazole antifungal therapy
- (2011) C. G. Baxter et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India
- (2011) A. Chowdhary et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Adverse interactions between antifungal azoles and vincristine: review and analysis of cases
- (2011) Brad Moriyama et al. MYCOSES
- A Clinical Isolate of Candida albicans with Mutations in ERG11 (Encoding Sterol 14 -Demethylase) and ERG5 (Encoding C22 Desaturase) Is Cross Resistant to Azoles and Amphotericin B
- (2010) C. M. Martel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Environmental Study of Azole-Resistant Aspergillus fumigatus and Other Aspergilli in Austria, Denmark, and Spain
- (2010) K. L. Mortensen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Azole Binding Properties of Candida albicans Sterol 14- Demethylase (CaCYP51)
- (2010) A. G. S. Warrilow et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy and Safety of Posaconazole for Chronic Pulmonary Aspergillosis
- (2010) Timothy W. Felton et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
- (2010) John R. Perfect et al. CLINICAL INFECTIOUS DISEASES
- Clinical Evidence of Interaction Between Itraconazole and Nonnucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients with Disseminated Histoplasmosis
- (2009) Roberto A Andrade et al. ANNALS OF PHARMACOTHERAPY
- Three-Dimensional Model of Lanosterol 14 -Demethylase from Cryptococcus neoformans: Active-Site Characterization and Insights into Azole Binding
- (2009) C. Sheng et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes
- (2009) E. Dannaoui et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Possible Environmental Origin of Resistance of Aspergillus fumigatus to Medical Triazoles
- (2009) E. Snelders et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Toxicodynamics of Itraconazole: Implications for Therapeutic Drug Monitoring
- (2009) Jodi M. Lestner et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
- (2009) Peter G. Pappas et al. CLINICAL INFECTIOUS DISEASES
- The alternative oxidase of Candida albicans causes reduced fluconazole susceptibility
- (2009) L. Yan et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Effects of cyclosporin A and itraconazole on the pharmacokinetics of atorvastatin in rats1
- (2008) Jing DONG et al. ACTA PHARMACOLOGICA SINICA
- Randomized Controlled Trial of Oral Antifungal Treatment for Severe Asthma with Fungal Sensitization
- (2008) David W. Denning et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Clinical Practice Guidelines for the Management of Blastomycosis: 2008 Update by the Infectious Diseases Society of America
- (2008) Stanley W. Chapman et al. CLINICAL INFECTIOUS DISEASES
- Therapeutic drug monitoring for triazoles
- (2008) William W Hope et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Cardiovascular adverse effects during itraconazole therapy
- (2008) S-L. Fung et al. EUROPEAN RESPIRATORY JOURNAL
- Itraconazole Oral Solution Enhanced Vincristine Neurotoxicity in Five Patients with Malignant Lymphoma
- (2008) Naoto Takahashi et al. INTERNAL MEDICINE
- Development and evaluation of novel itraconazole-loaded intravenous nanoparticles
- (2008) Wei Chen et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- In Vitro Survey of Triazole Cross-Resistance among More than 700 Clinical Isolates of Aspergillus Species
- (2008) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism
- (2008) Eveline Snelders et al. PLOS MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now